Liver damage during interferon therapy for chronic myeloid leukaemia.
Philippe
P
P
Fialip
J
J
Souweine
B
B
Aumaitre
O
O
Marcheix
J C
JC
Lavarenne
J
J
D000368:Aged; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008107:Liver Diseases / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins